Last Updated:
Name Designation Appointment Date Status
Fawaz Mohamed Manu

Appointed as Director since May 2025

 Director 07-May-2025 Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Paxole Pharma Private Limited.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.
Cholakkal Vipindas

Appointed as Director since May 2025

 Director 07-May-2025 Current
Hamdan Parachikkottil

Appointed as Director since May 2025

 Director 07-May-2025 Current
Chooriyottil Jayaprasad

Appointed as Director since May 2025

 Director 07-May-2025 Current

People Timeline

Explore the timeline of key personnel in Paxole Pharma Private Limited's leadership journey.

Contact Details
  • Address 80/3 Vijinapur Village, Old Madras Road Kr Puram, Bangalore North Karnataka, 560016, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 560016
  • Country India
  • Website -
Frequently Asked Questions
You can contact Paxole Pharma Private Limited through their registered address at 80/3 Vijinapur Village, Old Madras Road Kr Puram, Bangalore North Karnataka, 560016, India, or via their website if available. Social media links are also provided where applicable.
The current directors of Paxole Pharma Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • Fawaz Mohamed Manu
  • Cholakkal Vipindas
  • Hamdan Parachikkottil
  • Chooriyottil Jayaprasad
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available